These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 16116145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Perron R.
    Neurology; 2005 Apr 26; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15858865
    [No Abstract] [Full Text] [Related]

  • 3. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Stetz SA.
    Neurology; 2005 Aug 23; 65(4):657-8; author reply 657-8. PubMed ID: 16118861
    [No Abstract] [Full Text] [Related]

  • 4. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Rackley RJ.
    Neurology; 2005 Aug 23; 65(4):657-8; author reply 657-8. PubMed ID: 16118860
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Burkhardt RT, Leppik IE, Blesi K, Scott S, Gapany SR, Cloyd JC.
    Neurology; 2004 Oct 26; 63(8):1494-6. PubMed ID: 15505173
    [Abstract] [Full Text] [Related]

  • 8. Conflicts of interest with the health industry.
    Dubois MY.
    Pain Med; 2006 Oct 26; 7(5):463-5. PubMed ID: 17014609
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Financial disclosure for review authors.
    Nat Neurosci; 2003 Oct 26; 6(10):997. PubMed ID: 14513027
    [No Abstract] [Full Text] [Related]

  • 11. Psychotropic effects of antiepileptic drugs.
    Boylan LS.
    Neurology; 2007 Oct 16; 69(16):1640; author reply 1640. PubMed ID: 17938375
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
    Sethi NK, Torgovnick J, Arsura E.
    Neurology; 2007 Aug 28; 69(9):937; author reply 937-8. PubMed ID: 17724302
    [No Abstract] [Full Text] [Related]

  • 14. Editorial policies on financial disclosure.
    Jacobson MF, Sharpe VA, Angell M, Ashford NA, Blum A, Chary LK, Cho M, Coull BC, Davis D, Doolittle RF, Egilman D, Epstein SS, Greenberg M, Hooper K, Huff J, Joshi TK, Krimsky S, LaDou J, Levenstein C, Miles S, Needleman H, Pellegrino ED, Ravanesi B, Sass J, Schecter A, Schneiderman JS, Schubert D, Soffritti M, Suzuki D, Takaro TK, Temple NJ, Terracini B, Thompson A, Wallinga D, Wing S.
    Nat Neurosci; 2003 Oct 28; 6(10):1001. PubMed ID: 14513030
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients.
    Deleu D, Aarons L, Ahmed IA.
    Arch Med Res; 2005 Oct 28; 36(1):49-53. PubMed ID: 15777995
    [Abstract] [Full Text] [Related]

  • 18. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ, Gross RA, Tomaszewski KJ, Zingaro WM, Haskins LS.
    Neurology; 2008 Aug 12; 71(7):525-30. PubMed ID: 18695164
    [Abstract] [Full Text] [Related]

  • 19. Dilantin jeopardy: avoiding the dangers of phenytoin.
    Schlicher ML.
    Medsurg Nurs; 1998 Dec 12; 7(6):343-7, 356. PubMed ID: 10036438
    [Abstract] [Full Text] [Related]

  • 20. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM, Ignjatovic Ristic D.
    Expert Opin Drug Metab Toxicol; 2015 Mar 12; 11(3):329-32. PubMed ID: 25440299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.